After Roche lost its top pharma executive Dan?O’Day?to Gilead Sciences, the cancer giant tapped Genentech head?Bill Anderson for the post, leaving a gap at the top of its?crucial?unit. Now, Genentech has?named?Roche executive Alexander Hardy to be its nex